Emerging Infectious Diseases (Apr 2024)

A One Health Perspective on Salmonella enterica Serovar Infantis, an Emerging Human Multidrug-Resistant Pathogen

  • Jennifer Mattock,
  • Marie Anne Chattaway,
  • Hassan Hartman,
  • Timothy J. Dallman,
  • Anthony M. Smith,
  • Karen Keddy,
  • Liljana Petrovska,
  • Emma J. Manners,
  • Sanelisiwe T. Duze,
  • Shannon Smouse,
  • Nomsa Tau,
  • Ruth Timme,
  • Dave J. Baker,
  • Alison E. Mather,
  • John Wain,
  • Gemma C. Langridge

DOI
https://doi.org/10.3201/eid3004.231031
Journal volume & issue
Vol. 30, no. 4
pp. 701 – 710

Abstract

Read online

Salmonella enterica serovar Infantis presents an ever-increasing threat to public health because of its spread throughout many countries and association with high levels of antimicrobial resistance (AMR). We analyzed whole-genome sequences of 5,284 Salmonella Infantis strains from 74 countries, isolated during 1989–2020 from a wide variety of human, animal, and food sources, to compare genetic phylogeny, AMR determinants, and plasmid presence. The global Salmonella Infantis population structure diverged into 3 clusters: a North American cluster, a European cluster, and a global cluster. The levels of AMR varied by Salmonella Infantis cluster and by isolation source; 73% of poultry isolates were multidrug resistant, compared with 35% of human isolates. This finding correlated with the presence of the pESI megaplasmid; 71% of poultry isolates contained pESI, compared with 32% of human isolates. This study provides key information for public health teams engaged in reducing the spread of this pathogen.

Keywords